Ventegra Launches Real-time Rebate Capability at Point of Prescription Adjudication
Ventegra, a Nonprofit Public Benefit Corporation that has been pioneering Medical Benefit Management (MBM) solutions for more than 20 years — delivering innovative, value-driven pharmacy and medical benefits that balance drug spend control with quality patient care — today announces the launch of its Real-Time Rebate (RTR) capability following a successful pilot program.
US Patent and Trademark Office Grants Patent to Ventegra for Its Acquisition Cost Index (ACI) Cost-Plus Pricing Reimbursement Technology Platform for Prescription Drugs
The US Patent and Trademark Office (USPTO) has granted US patent number 11,023,979 B2 (June 1, 2021) that covers Ventegra’s Acquisition Cost Index (ACI) cost-based reimbursement technology (Reference Price Index) through 2034.
